Stockscreener 앱 받기
1.20
4.35%
0.05
Repare Therapeutics Inc 주식(RPTX)의 최신 뉴스
Cathie Wood’s ARK ETF focuses on GitLab stock, sheds Repare Therapeutics - Investing.com Australia
Cathie Wood's Ark Invest Offloads Uipath, Prime Medicine, And Repare Therapeutics - Benzinga
Cathie Wood's Ark Invest Offloads UiPath, Prime Medicine, And Repare Therapeutics - Benzinga
Cathie Wood’s ARK ETF adjusts portfolio, sells Repare Therapeutics stock - Investing.com
Repare Therapeutics Stock Hits 52-Week Low at $0.98 Amid Market Challenges - Investing.com
Petri Dish: Vertex halts type 1 diabetes trial; Watertown manufacturer sold - The Business Journals
Repare Therapeutics Appoints Steve Forte CEO - citybiz
Repare Therapeutics appoints CFO as new CEO - MSN
Repare Therapeutics Appoints Steve Forte as CEO to Succeed Lloyd Segal - MarketScreener
Repare Therapeutics Announces Leadership Changes in 2025 - TipRanks
Repare Therapeutics Names Forte as President, CEO - MarketWatch
Repare Therapeutics CEO Lloyd Segal resigns, Steve Forte succeeds - TipRanks
Repare's New CEO Takes Helm With 3 Clinical Trial Readouts Coming in 2025 - Stock Titan
Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace
Cathie Wood’s ARK trims Illumina, exits Repare Therapeutics stock By Investing.com - Investing.com South Africa
Cathie Wood’s ARK trims Illumina, exits Repare Therapeutics stock - Investing.com
Repare Therapeutics stock hits 52-week low at $1.05 By Investing.com - Investing.com Australia
Repare Therapeutics stock hits 52-week low at $1.05 - Investing.com
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen - Benzinga
Fierce Biotech Layoff Tracker 2025: Cargo lays off 90% of staff; Empress halves workforce - Fierce Biotech
Repare therapeutics’ chief medical officer sells shares for $4,099 By Investing.com - Investing.com Australia
Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta - Benzinga
Repare therapeutics’ chief scientific officer sells $6,396 in shares - Investing.com India
Repare therapeutics’ chief scientific officer sells $6,396 in shares By Investing.com - Investing.com South Africa
Repare therapeutics CEO Segal Lloyd Mitchell sells $24,144 in shares By Investing.com - Investing.com South Africa
Repare therapeutics CEO Segal Lloyd Mitchell sells $24,144 in shares - Investing.com
Repare Therapeutics CEO Sells Shares to Cover Tax Obligations - TradingView
HC Wainwright Issues Pessimistic Forecast for Repare Therapeutics (NASDAQ:RPTX) Stock Price - MarketBeat
What Makes Repare Therapeutics (RPTX) a New Buy Stock - Yahoo Finance
Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Bluefield Daily Telegraph
Repare Therapeutics stock target cut to $5 at H.C. Wainwright - Investing.com India
Repare Therapeutics stock target cut to $5 at H.C. Wainwright By Investing.com - Investing.com Canada
Strategic Pipeline Focus and Financial Stability Support Buy Rating for Repare Therapeutics - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
Repare Therapeutics (NASDAQ:RPTX) Announces Quarterly Earnings Results, Beats Estimates By $0.10 EPS - MarketBeat
New Hires at Repare Get Stock Options as Share Price Shows 67% Drop - Stock Titan
2.51%
자본화:
|
볼륨(24시간):